UBE2M
NEDD8-conjugating enzyme Ubc12
Also known as: hUbc12, UBC12, UBC12_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61081
- Gene
- UBE2M
- Ensembl
- ENSG00000130725
- Chromosome
- 19
- Canonical length
- 183 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol
OverviewNCBI Gene
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein is linked with a ubiquitin-like protein, NEDD8, which can be conjugated to cellular proteins, such as Cdc53/culin. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
183 residues, UniProt reviewed canonical sequence.
>P61081|UBE2M
1 MIKLFSLKQQ KKEEESAGGT KGSSKKASAA QLRIQKDINE LNLPKTCDIS FSDPDDLLNF
61 KLVICPDEGF YKSGKFVFSF KVGQGYPHDP PKVKCETMVY HPNIDLEGNV CLNILREDWK
121 PVLTINSIIY GLQYLFLEPN PEDPLNKEAA EVLQNNRRLF EQNVQRSMRG GYIGSTYFER
181 CLKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2M can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 219 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 219 nTPM
- amygdala: 194 nTPM
- skeletal muscle: 170 nTPM
- basal ganglia: 140 nTPM
- hippocampal formation: 130 nTPM
- heart muscle: 129 nTPM
Single-cell type
- megakaryocytes: 161 nCPM
- breast lactating cells: 133 nCPM
- alveolar cells type 2: 116 nCPM
- suprabasal keratinocytes: 116 nCPM
- erythrocyte progenitors: 115 nCPM
- smooth muscle cells: 107 nCPM
Immune cell
- neutrophil: 10 nTPM
- basophil: 6.8 nTPM
- plasmacytoid DC: 6.7 nTPM
- eosinophil: 4.2 nTPM
- naive B-cell: 3.8 nTPM
- classical monocyte: 3.6 nTPM
Brain region
- cerebral cortex: 178 nTPM
- white matter: 155 nTPM
- basal ganglia: 151 nTPM
- amygdala: 142 nTPM
- hypothalamus: 140 nTPM
- pons: 138 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.8
- gnomAD missense Z
- 2.29
- DepMap mean gene effect
- -1.21
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- post-translational protein modification
- protein modification process
- protein neddylation
- regulation of postsynapse assembly
Molecular functions
- ATP binding
- NEDD8 conjugating enzyme activity
- NEDD8 transferase activity
- ubiquitin-protein transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2M in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2M as an antibody target. Whether an autoantibody or antibody against UBE2M could matter depends on whether native UBE2M is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2M is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2M as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...